Deer Management Co. LLC T Scan Therapeutics, Inc. Transaction History
Deer Management Co. LLC
- $612 Million
- Q3 2024
A detailed history of Deer Management Co. LLC transactions in T Scan Therapeutics, Inc. stock. As of the latest transaction made, Deer Management Co. LLC holds 1,245,504 shares of TCRX stock, worth $5.13 Million. This represents 1.01% of its overall portfolio holdings.
Number of Shares
1,245,504
Previous 1,245,504
-0.0%
Holding current value
$5.13 Million
Previous $7.29 Million
14.88%
% of portfolio
1.01%
Previous 1.58%
Shares
2 transactions
Others Institutions Holding TCRX
# of Institutions
89Shares Held
41.8MCall Options Held
0Put Options Held
0-
Lynx1 Capital Management LP San Juan, PR5.22MShares$21.5 Million9.31% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5MShares$20.6 Million1.08% of portfolio
-
Black Rock Inc. New York, NY4.46MShares$18.4 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.4MShares$18.1 Million0.04% of portfolio
-
Bvf Inc San Francisco, CA2.99MShares$12.3 Million0.47% of portfolio
About TScan Therapeutics, Inc.
- Ticker TCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,929,800
- Market Cap $78M
- Description
- TScan Therapeutics, Inc., a preclinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell therapies for the treatment of patients with cancer. It is developing TSC-100 and TSC-101 for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell ...